These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1393260)
21. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets. Schwanstecher M; Mnner K; Panten U Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319 [TBL] [Abstract][Full Text] [Related]
23. Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline. Ishida-Takahashi A; Horie M; Tsuura Y; Ishida H; Ai T; Sasayama S Br J Pharmacol; 1996 Apr; 117(8):1749-55. PubMed ID: 8732286 [TBL] [Abstract][Full Text] [Related]
24. Sulphonylurea binding in rat isolated glomeruli: pharmacological characterization and dependence on cell metabolism and cytoskeleton. Metzger F; Löffler C; Quast U Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):141-9. PubMed ID: 9050005 [TBL] [Abstract][Full Text] [Related]
25. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets. Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141 [TBL] [Abstract][Full Text] [Related]
26. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells. Best L; Benington S Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927 [TBL] [Abstract][Full Text] [Related]
27. Insulinotropic effect of new glibenclamide isosteres. Ouedraogo R; Nguyen QA; Kane MH; Dunne MJ; Pochet L; Masereel B; Lebrun P J Pharmacol Exp Ther; 1999 May; 289(2):625-31. PubMed ID: 10215632 [TBL] [Abstract][Full Text] [Related]
28. Potassium permeability of fetal rat pancreatic islets: abnormal sensitivity to glucose. Wahl MA; Waldner RG; Ammon HP Life Sci; 1992; 51(21):1631-7. PubMed ID: 1435074 [TBL] [Abstract][Full Text] [Related]
29. The beta-cell glibenclamide receptor is an ADP-binding protein. Niki I; Nicks JL; Ashcroft SJ Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099 [TBL] [Abstract][Full Text] [Related]
30. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. Ohnota H; Koizumi T; Tsutsumi N; Kobayashi M; Inoue S; Sato F J Pharmacol Exp Ther; 1994 May; 269(2):489-95. PubMed ID: 8182516 [TBL] [Abstract][Full Text] [Related]
31. Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11. Khan RN; Hales CN; Ozanne SE; Adogu AA; Ashford ML Proc Biol Sci; 1993 Sep; 253(1338):225-31. PubMed ID: 7694299 [TBL] [Abstract][Full Text] [Related]
32. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content. Anello M; Gilon P; Henquin JC Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920 [TBL] [Abstract][Full Text] [Related]
33. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism. Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916 [TBL] [Abstract][Full Text] [Related]
34. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine. Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues. Becker B; Antoine MH; Nguyen QA; Rigo B; Cosgrove KE; Barnes PD; Dunne MJ; Pirotte B; Lebrun P Br J Pharmacol; 2001 Sep; 134(2):375-85. PubMed ID: 11564656 [TBL] [Abstract][Full Text] [Related]
36. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels. Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830 [TBL] [Abstract][Full Text] [Related]
37. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells. Jonas JC; Plant TD; Henquin JC Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388 [TBL] [Abstract][Full Text] [Related]
38. How do sulfonylureas approach their receptor in the B-cell plasma membrane? Zünkler BJ; Trube G; Panten U Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):328-32. PubMed ID: 2682269 [TBL] [Abstract][Full Text] [Related]
39. 8-Methoxypsoralen blocks ATP-sensitive potassium channels and stimulates insulin release. Szewczyk A; De Weille JR; Lazdunski M Eur J Pharmacol; 1992 Jun; 216(2):323-6. PubMed ID: 1397018 [TBL] [Abstract][Full Text] [Related]
40. Binding of K(ATP) channel modulators in rat cardiac membranes. Löffler-Walz C; Quast U Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]